Rising healthcare premiums are increasingly being discussed alongside the rapid expansion of artificial intelligence across the U.S. healthcare system. Yet the relationship is more complicated than a simple “AI makes insurance more expensive” narrative: current evidence points primarily to underlying medical costs, while AI is simultaneously being deployed as a tool that insurers and providers hope can improve efficiency and contain spending.

Healthcare Costs Remain the Core Driver

Recent analysis from KFF indicates that the main pressure behind higher health insurance premiums is underlying healthcare spending, particularly hospital care, physician and clinical services, and prescription drugs. U.S. national health spending reached approximately $5.3 trillion in 2024, with hospitals representing the largest component. KFF also estimates that hospitals accounted for about 40% of healthcare spending growth between 2022 and 2024.

This distinction matters for investors and policymakers because AI-related expenditure represents only one component of a much larger healthcare cost structure. Hospital consolidation, negotiated prices, utilization, pharmaceutical costs and labor expenses can all influence the premiums ultimately paid by employers and households. Consequently, attributing the entire increase in premiums to AI would overlook the broader economics of the U.S. healthcare system.

AI Is Creating a New Cost-and-Efficiency Equation

At the same time, AI is changing how insurers and hospitals manage those expenses. Hospitals and insurers are increasingly using AI for claims review, billing, prior authorization and clinical workflows. Reuters reported that U.S. hospitals accounted for approximately $1 billion of the $1.4 billion spent on healthcare AI in 2025, while insurers accounted for about $50 million. The technology is being deployed partly because both sides expect substantial efficiency gains.

Insurers are also presenting AI as a potential mechanism for reducing future medical costs. Cigna said in July that AI tools designed to identify patients with chronic or complex conditions could save customers approximately $200 million in medical expenses over three years through earlier intervention and improved care coordination.

Why AI Could Still Affect Premiums Indirectly

The financial impact of AI is therefore likely to depend on how its benefits and costs are distributed. Automation may reduce administrative expenses, identify billing discrepancies and help clinicians intervene earlier, potentially lowering expensive medical events. However, competing AI systems used by insurers and healthcare providers can also create an “arms race” in claims management and reimbursement, with uncertain implications for overall system costs.

For Israeli investors monitoring the global healthcare sector, the development creates a broader technology and healthcare convergence theme. Companies providing AI infrastructure, clinical software, data analytics and healthcare services could benefit from increasing adoption, but regulatory scrutiny, cybersecurity exposure, implementation costs and uncertain monetization remain important downside risks.

Looking ahead, the key indicator will be whether AI produces measurable reductions in medical spending rather than simply shifting costs between insurers, hospitals and patients. Investors will likely watch healthcare utilization, medical-loss ratios, hospital pricing, insurer technology spending and evidence of AI-driven productivity gains. If those efficiencies become measurable at scale, AI could eventually help moderate cost growth; if implementation expenses and competing automated systems rise faster than savings, the technology may add another layer of complexity to an already expensive healthcare ecosystem.